TRANSIRNA
LIVE

Serial Number

90272202

Owner

imnewrun Biosciences, Inc.

Attorney

Lenny R. Jiang

Filing Date

Oct 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TRANSIRNA Trademark

Serial Number: 90272202 • Registration: 7342045

TRANSIRNA is a trademark filed by imnewrun Biosciences, Inc. on October 22, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

imnewrun Biosciences, Inc. (10 trademarks)

A-5F, N Center, 2066, Seobu-ro
Gyeonggi-do 16419 , KR

Entity Type: 03

IMNEWRUN, INC. (6 trademarks)

A-5F, N CENTER, 2066, SEOBU-RO,
SUWON-SI, GYEONGGI-DO 000 , KR

Entity Type: 03

Trademark Details

Filing Date

October 22, 2020

Registration Date

April 2, 2024

Published for Opposition

January 16, 2024

Goods & Services

preparations for gene recombination for medical purposes; oligonucleotides for medical purposes; recombinant nucleic acid for medical purposes; nucleic acid for medical purposes; preparations for nucleic acid for medical purposes; medicated scalp treatments; medicated lotions and creams for the body, skin, face, and hands; medicated creams for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated skin care preparations; pharmaceutical preparations for treating epidermal problems

preparations for gene recombination for scientific or laboratory purposes; recombinant nucleic acid for scientific or laboratory purposes; nucleic acid for scientific or laboratory purposes; preparations for nucleic acid for scientific or laboratory purposes; oligopeptides for use in the manufacture of cosmetics; peptide substrates for scientific purposes

research and development of technology for biotechnology; scientific research in the fields of biomedicine; pharmaceutical products development; medical studies; medicine research; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; laboratory research in the field of biology; development of biologics; laboratory research in the field of gene expression; scientific research for medical purposes; research and development of amino acid for medical purposes; research and development of peptide for medical purposes; research and development of oligonucleotides for medical purposes; research and development of technology for medicinal chemical manufacturing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2023 CNSA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 29, 2022 ASGN
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2022 CRFA
ASSIGNED TO LIE
Mar 30, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 22, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 8, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 8, 2021 GNSL
SUSPENSION LETTER WRITTEN
Oct 8, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 23, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 10, 2020 NWOS
NEW APPLICATION ENTERED
Oct 26, 2020 NWAP